Abstract 16353: Effects of Dapagliflozin on Physical and Social Activity Limitations in Patients With Heart Failure and Reduced Ejection Fraction: An Analysis of DAPA-HF

Kieran F. Docherty,Mikhail Kosiborod,Silvio E. Inzucchi,Lars Køber,Anna Maria Langkilde,Felipe Martinez,Olof Bengtsson,Piotr Ponikowski,Marc S. Sabatine,Mikaela SjÃ¶strand,Scott D. Solomon,Pardeep S. Jhund,John J.V. McMurray

Abstract 16353: Effects of Dapagliflozin on Physical and Social Activity Limitations in Patients With Heart Failure and Reduced Ejection Fraction: An Analysis of DAPA-HF

2020

Kieran F. Docherty
Mikhail Kosiborod
Silvio E. Inzucchi
Lars Køber
Anna Maria Langkilde
Felipe Martinez
Olof Bengtsson
Piotr Ponikowski
Marc S. Sabatine
Mikaela SjÃ¶strand
Scott D. Solomon
Pardeep S. Jhund
John J.V. McMurray

Background: Patients with heart failure and reduced ejection fraction (HFrEF) suffer limitations in physical and social activities. We examined whether the SGLT2 inhibitor dapagliflozin improved th...

Keywords:

in patient
social activity
symptom management
Quality of life
Ejection fraction
Diabetes type ii
Heart failure
Cardiology
Internal medicine
Medicine
Dapagliflozin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations